At genomic level, the majority of somatic CN deletion induces simultaneous deletion of the passenger genes chromosomally adjacent to the driver genes (e.g., RB1), thereby facilitating “collateral lethality” as a new therapeutic strategy to target the neighboring genes for cancer treatment [18, 19, 20]. Here, RB1 is linked to cancer.